Company
Oxurion is a company specializing in acquiring majority stakes in promising European pharmaceutical subcontractors. Our ambition is to build an integrated group of subcontractors serving healthcare stakeholders. Oxurion holds a 72% stake in Axiodis CRO, a subcontractor specialized in biometrics.
Our Mission
Our Mission
To prevent blindness by pioneering life changing treatments that address unmet medical needs in ophthalmology, with a focus on retinal diseases including Age-related Macular Degeneration (AMD).
Oxurion is headquartered in Leuven, Belgium, and is listed on Euronext Brussels under the symbol OXUR
Your Vision is Our Vision
We are united by the shared goal of helping people to see better.
We are collaborative, resilient, and turn challenges into opportunities.
Team
Executive Team
Pascal Ghoson
CEO/CFO
Team
BOARD OF DIRECTORS
Charles Paris de Bollardière
Chairman Of The Board
James Hartmann
Independent Non-Executive Director
Pascal Ghoson
CEO/CFO
Nelly Souleymane
Independent Non-Executive Director
Let's Talk
To inquire regarding partnership opportunities with Oxurion, please contact: